White matter microstructure associated with anhedonia among individuals with bipolar disorders and high-risk for bipolar disorders
Carregando...
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER
Autores
DIAZ, Alexandre Paim
FERNANDES, Brisa S.
TEIXEIRA, Antonio Lucio
MWANGI, Benson
HASAN, Khader M.
WU, Mon-Ju
SELVARAJ, Sudhakar
Citação
JOURNAL OF AFFECTIVE DISORDERS, v.300, p.91-98, 2022
Resumo
Background: Anhedonia - a key symptom of depression - is highly associated with poorer outcomes and suicidal behavior. Alterations in the circuitry of reward-related brain regions have been robustly associated with anhedonia in unipolar depression, but not bipolar disorder (BD). We investigated white matter microstructures associated with anhedonia in participants with BD types I and II and first-degree relatives of patients with BD (BD-siblings). Methods: Eighty participants (BD types I and II: 56 [70%], and BD-siblings: 24 [30%]) underwent diffusion tensor imaging (DTI); Fractional anisotropy (FA) of different tracts were computed. Anhedonia was assessed using item 8, (""inability to feel"") of the MADRS scale. General linear models were used to compare the FA of different tracts in participants with and without anhedonia controlling for several clinical and demographic variables. Results: The mean age of the sample was 37 (+/- 11) years old, and 68.8% were female. Participants with anhedonia (32.5%) presented lower mean FA in the left uncinate fasciculus (UF) (p = 0.005), right temporal endings of the superior longitudinal fasciculus (SLFT) (p = 0.04), and in the left and right parietal endings of the superior longitudinal fasciculus (SLFP) (p = 0.003, and p = 0.04, respectively). Similar comparisons between participants with or without current depressive episodes and between participants with or without inner tension according to the MADRS did not show significant differences, specificity of the findings for anhedonia. Conclusions: Lower FA in the left UF and SLF are potential neuroimaging markers of anhedonia in individuals with BD and high-risk for BD.
Palavras-chave
Bipolar disorders, Neuroimaging, Anhedonia, Orbitofrontal cortex, Nucleus accumbens, Diffusion tensor imaging, Biomarker
Referências
- Alba-Ferrara LM, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00009
- Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011
- Ameli R, 2014, PEERJ, V2, DOI 10.7717/peerj.429
- Auerbach RP, 2019, JAMA PSYCHIAT, V76, P571, DOI 10.1001/jamapsychiatry.2018.4600
- Ballard ED, 2017, J AFFECT DISORDERS, V218, P195, DOI 10.1016/j.jad.2017.04.057
- Baydin S, 2016, OPER NEUROSURG, V12, P269, DOI 10.1227/NEU.0000000000001133
- Berridge KC, 2015, NEURON, V86, P646, DOI 10.1016/j.neuron.2015.02.018
- Bonanni L, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55080458
- Brodaty H, 2010, INT PSYCHOGERIATR, V22, P426, DOI 10.1017/S1041610209991335
- Cole J, 2012, BRIT J PSYCHIAT, V201, P33, DOI 10.1192/bjp.bp.111.100594
- Dillon DG, 2018, DEPRESS ANXIETY, V35, P440, DOI 10.1002/da.22734
- Drevets WC, 2001, BIOL PSYCHIAT, V49, P81, DOI 10.1016/S0006-3223(00)01038-6
- Drysdale AT, 2017, NAT MED, V23, P28, DOI 10.1038/nm.4246
- Duarte JA, 2016, REV BRAS PSIQUIATR, V38, P167, DOI 10.1590/1516-4446-2015-1793
- Favre P, 2019, NEUROPSYCHOPHARMACOL, V44, P2285, DOI 10.1038/s41386-019-0485-6
- First, 1996, STRUCTURED CLIN INTE
- Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021
- Frazier JA, 2007, BIPOLAR DISORD, V9, P799, DOI 10.1111/j.1399-5618.2007.00482.x
- Gorwood Philip, 2008, Dialogues Clin Neurosci, V10, P291
- Gross DW, 2011, EPILEPSIA, V52, P32, DOI 10.1111/j.1528-1167.2011.03149.x
- Grover VPB, 2015, J CLIN EXP HEPATOL, V5, P246, DOI 10.1016/j.jceh.2015.08.001
- Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129
- Harnett NG, 2021, DEPRESS ANXIETY, V38, P79, DOI 10.1002/da.23104
- Hasan KM, 2009, BRAIN RES, V1276, P67, DOI 10.1016/j.brainres.2009.04.025
- Horan WP, 2006, SCHIZOPHRENIA BULL, V32, P259, DOI 10.1093/schbul/sbj009
- Husain M, 2018, NAT REV NEUROSCI, V19, P470, DOI 10.1038/s41583-018-0029-9
- Jiang WH, 2020, NEUROIMAGE-CLIN, V26, DOI 10.1016/j.nicl.2019.101989
- Kreilkamp BAK, 2017, NEUROIMAGE-CLIN, V14, P67, DOI 10.1016/j.nicl.2017.01.003
- Lyden H, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.21
- Madonna D, 2019, BRAZ J PSYCHIAT, V41, P336, DOI 10.1590/1516-4446-2018-0108
- McMakin DL, 2012, J AM ACAD CHILD PSY, V51, P404, DOI 10.1016/j.jaac.2012.01.011
- Melloni EMT, 2020, J AFFECT DISORDERS, V274, P1049, DOI 10.1016/j.jad.2020.05.146
- Meoded A., 2017, REFERENCE MODULE NEU
- MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382
- Mwangi B, 2013, NEUROIMAGE, V75, P58, DOI 10.1016/j.neuroimage.2013.02.055
- Nakajima R, 2020, BRAIN IMAGING BEHAV, V14, P2817, DOI 10.1007/s11682-019-00187-4
- Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087
- Pushkarskaya H, 2019, J PSYCHIATR RES, V109, P202, DOI 10.1016/j.jpsychires.2018.11.029
- Rizvi SJ, 2016, NEUROSCI BIOBEHAV R, V65, P21, DOI 10.1016/j.neubiorev.2016.03.004
- Robbins TW, 2016, SCIENCE, V351, P24, DOI 10.1126/science.aad9698
- Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267
- Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005
- Squarcina L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178089
- Vijayalaxmi, 2015, MUTAT RES-REV MUTAT, V764, P51, DOI 10.1016/j.mrrev.2015.02.002
- Vinckier F, 2017, EUR PSYCHIAT, V44, P1, DOI 10.1016/j.eurpsy.2017.02.485
- Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094
- WATSON D, 1995, J ABNORM PSYCHOL, V104, P3, DOI 10.1037/0021-843X.104.1.3
- Wei Q, 2020, J AFFECT DISORDERS, V264, P163, DOI 10.1016/j.jad.2019.11.120
- Wilcox CE, 2016, AM J PSYCHIAT, V173, P344, DOI 10.1176/appi.ajp.2015.15060710
- Xu E., 2021, J AFFECT DISORDERS, V297, P208
- Zhang B, 2016, BRAIN IMAGING BEHAV, V10, P920, DOI 10.1007/s11682-015-9457-6